Safety of the Russian antiviral drug Kagocel

Borovskaya T.G.

doi:https://doi.org/10.17116/terarkh2017891193-99

Close metadata

Recommended articles:

L-lysine aescinate for back pain: a systematic review. Russian Journal of Pain. 2024;(4):46-54

Efficacy and safety of topical antibiotic therapy in patients with acute external bacterial otitis: results of a retrospective study. Russian Bulletin of Otorhinolaryngology. 2024;(6):24-27

Open observational study with a retrospective analysis of the efficacy and tolerability of aceclofenac in patients with acute non-specific low back pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):99-105

Model selection for determination of primary stability of dental implants in experimental studies. Stomatology. 2024;(6-2):53-57

On the issue of choosing anesthesia methods: a comparison of general medicine and clinical dentistry. Stomatology. 2025;(1):76-80

Efficacy and safety of fonturacetam in asthenia: a systematic review and meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):69-79

Post-exposure prophylaxis of influenza and ARVI. Results of a double-blind, placebo-controlled clinical trial of Meglumine acridone acetate and its pharmacoeconomic rationale. Russian Journal of Preventive Medicine. 2025;(4):57-66

Experience of using ribociclib in the therapy of metastatic breast cancer in a regional oncological dispensary. P.A. Herzen Journal of Oncology. 2025;(3):89-93

Practical aspects of clinical and laboratory trials of medical devices for immunohistochemical studies. Communication 1. Trials of the instrument for immunohistochemical staining. Laboratory Service. 2025;(2):11-18

Comparative study of the neuroprotective effects of the drug Cytoflavin and citicoline in a rats model of hemorrhagic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):85-95

Abstract:

The review gives summarized information on the preclinical data and clinical trials evaluating the safety of the antiviral drug Kagocel. It notes that the manufacturer of the drug pay special attention to the control of its impurity content. There is information on the development and validation of highly sensitive and specific high-performance liquid chromatography procedures, the application of which can guarantee that free gossypol impurities are absent in the drug. The results of preclinical toxicity study of Kagocel in experiments on laboratory animals are briefly reviewed; particular attention is paid to the investigation of the drug’s safety for the reproductive system of immature animals. It is noted that evaluation of the total toxic properties of Kagocel has revealed no signs of intoxication. Investigations of the reproductive toxicity of Kagocel have showed no effect on spermatogenesis. A set of experimental studies of the long-term effects of the use of Kagocel in different regimens has confirmed that the drug has no negative effect on the reproductive organs in the offspring of experimental rats and on its development. Many clinical trials, including those with participation of children aged 2 years or older, have provided important data on drug safety. The results given in the review lead to the conclusion that the use of the antiviral drug Kagocel in both general and pediatric practice is proven safe.

Keywords:

safety

antiviral drug

Kagocel

preclinical study

reproductive toxicity

clinical trials

Authors:

Borovskaya T.G.

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia

Close metadata

References:

Karetkina GN. Influenza and colds: treatment and prevention in this epidemic season 2015—2016. Attending physician. 2015;11:56-59 (In Russ.)
Malmgaard L. Induction and regulation of IFNs during viral infection. J Interferon Cytokine Res. 2004;24(8):439-454.
Sadler AJ, Williams BR. Dynamiting viruses with MxA. Immunity. 2011;35 (4):491-493.
Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, Falcone V et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol. 2010;84(11):5670-5677.
Ershov FI Narovlyansky AN. Use of interferon inducers in viral infections. Questions of Virology. 2015;60(2):54-10. (In Russ.)
Mezernitsky YuL. Modern interferonogens in acute respiratory viral infections in children. Medical advice. 2015;14:81-83. (In Russ.)
Galegov GA, Narovlyansky AN, Sarymsakov AA et al. The effect of Kagocel on the reproduction of the herpes virus. Questions of virology. 2002;4:33-37 (In Russ.)
Ershov FI, Kiselev OI. Interferons and their inducers (from molecules to drugs). Moscow: GEOTAR-Media, 2005. (In Russ.)
Wang X, Howell CP, Chen F, Yin J, Jiang Y. Gossypol-А polyphenolic compound from cotton plant. Adv Food Nutr Res. 2009;58:215-263. https://doi.org/10.1016/S1043-4526(09)58006-0
Balakrishnan K, Wierda W G, Keating M J, Gandhi V. Gossypol, BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells. Blood. 2008;112(5):1971-1980.
Jiang J, Slivova V, Jedinak A, Sliva D. Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling. Clinical and Experimental Metastasis. 2012;29(2):165-178.
Ivana Cristina N. Gadelha, Nayanna Brunna S. Fonseca, Silvia Catarina S. Oloris, Marília M. Melo, Benito Soto-Blanco. Gossypol Toxicity from Cottonseed Products 2014;231635. Published online 2014. May 6. https://doi.org/10.1155/2014/231635.
de Peyster A, Wang YY. Genetic toxicity studies of gossypol. Mutat Res. 1993;297(3);293-312.
Waites G, Wang C, Griffin P. Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug. Int J Androl. 1998;21:8-12.
Auelbekov S A, Mirzaabdullaev A B, Aslanova D Kh, Kurchakov S, Achilova G Sh. Synthesis and antiviral activity of gossypol derivatives. Pharmaceutical Chemistry Journal. 1985;19(7):479-481.
Huang JX, Zhao SX, Gu ZP, Zhu YQ, Ji RY. Studies on the synthesis of gossypol derivatives and their antifertility action. Shengzhi Yu Biyun. 1986;6(1):48-52.
An T, Ouyang W, Pan W et al. Amino acid derivatives of the (–) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1. Antiviral Res. 2012;94(3):276-287.
Tilabayev KZ, Kamaev FG, Vypova NL et al. Synthesis, structure and «acute» toxicity of asymmetric aldehyde derivatives of gossypol. Bioorganic chemistry. 2010;36(3):423-428. (In Russ.)
Kiseleva IV, Rudoy BA, Pirogov AV, Tolmacheva NG. Validation of HPLC-method for the determination of gossypol in the substance Kagocel. Pharmacia. 2016;65(8):18-28. (In Russ.)
Sinitsin AP, Khodchenkov VP, Rudoy BA, Kazaishvili YG. Analysis of the possibility of releasing free gossypol from the preparation Kagocel under the influence of simulators of human digestive juices. Pharmacy 2017;8:18. (In Russ.)
Chandrashekar R, Kudle Rao, Jyothi CP, Lakshmi BN. Gossypol Analysis in Bt and Non-Bt Cotton Seed Extracts by High-Performance Liquid Chromatography (HPLC) International Journal of Herbal Medicine 2013;1:53-58.
Hron RJ, Kuk MS, Abraham G. Determination of free and total gossypol by high performance liquid chromatography. Journal of the American Oil Chemists’ Society March 1990;67(3):182-187.
Scientific opinion. Gossypol as undesirable substance in animal feed. The EFSA Journal. 2008;908:1-55.
Rybalkin SP, Kovaleva EV, Guskova TA, Savinova TB. Experimental evaluation of the effect of Kagocel on the generative function of animals. Toxicological Herald. 2013; 2(119):33-38. (In Russ.)
Vinokurov AA. Lymphoma of Hodgkin’s problem of reproduction in men. Fundamental research and clinical practice. 2013;6(3):258-273. (In Russ.)
Borovskaya TG, Poluektova ME, Vychuzhanina AV, Mashanova VA An experimental evaluation of the effect of Kagocel on reproductive function of rats with its introduction by prophylactic courses during the period of immaturity. Antibiotics and chemotherapy. 2017;62:3-4. (In Russ.)
Borovskaya TG, Poluektova ME, Vychuzhanina AV, Mashanova VA, Shchemerova Yu.A. Experimental evaluation of the effect of Kagocel on the generative function of male rat puberty. Bull experiment Biol And honey. 2017;163(2):176-179. (In Russ.)
Borovskaya TG, Poluektova ME, Vychuzhanin AV, Mashanov VA Shchemerova. Experimental evaluation of the effect of Kagocel on the reproductive function of experimental animals with its introduction in the infantile period of development. Toxicological Herald 2017;(3):42-49. (In Russ.)
Metodicheskie rekomendatsii po izucheniyu reproduktivnoi toksichnosti lekarstvennykh sredstv. /Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv. Ch. 1. M.: Izd. «FGBU NTsESMP», 2012:80-93. (In Russ.)
Sologub TV, Tsvetkov VV. Kagocel in the therapy of infl uenza and acute respiratory viral infections: Data analysis and systematization from the results of preclinical and clinical trials. Therapeutic archive. 2017;8:113-119. (In Russ.)
Maksakova VL, Vasil’eva IA, Erofeeva MK. The use of the drug Kagocel for the treatment and prevention of influenza and other acute respiratory viral infections. Medlain ekspress. 2009;1(201):42-46. (In Russ.)
Malyshev NA, Kolobukhina LV, Merkulova LN, Ershov FI. Modern approaches to increase the efficiency of treatment and prevention of influenza and other acute respiratory viral infections. Consilium Medicum. 2005;7(10):831-835. (In Russ.)
Merkulova LN, Kolobukhina LV, Kisteneva LB, Isaeva EI, Burtseva EI, Luk’yanova NA, Komarova TD, Kudryashova OV, Mashkova SA, Polonskii VO, Ospel’nikova TP, Narovlyanskii AN, Ershov FI. The therapeutic efficacy of Kagocel in the treatment of patients with uncomplicated influenza and influenza complicated by angina. Klinicheskaya farmakologiya i terapiya. 2002;11(5);21-23. (In Russ.)
Kharlamova FS, Uchaikin VF, Bevza SL, Ershov FI, Nesterenko VG, Sergeeva EM, Legkova TP, Feldfiks LI. Clinical Efficacy of Kagotsel in Treatment for Acute Respiratory Virus Infections (ARVI) in Children with Constrictive Laryngotracheitis. Detskie infektsii. 2008;(4):38-34. (In Russ.)
Vartanyan RV, Sergeeva EM, Cheshik SG. Evaluation of Therapeutic Efficacy of Kagocel® Preparation in Children of Early and Preschool Age with Acute Respiratory Viral Infections. Detskie infektsii. 2011;(1):36-41. (In Russ.)
Kharlamova FS, Kladova OV, Sergeeva EM, Shcherbakova AA, Yablonskaya KP, Legkova TP, Feldfiks LI, Rogova LA, Samson OS, Uchaykin VF. Clinical efficacy of Kagocel preparation for Treatment of Influenza and ARVI in Children Aged 2 to 6 Years. Detskie infektsii. 2010 (4);34-41. (In Russ.)
Harlamova FS, Kladova OV, Uchaykin VF, Cheshik SG, Vartanyan RV, Yablonskaya KP. Metapneumovirus and Bokavirus Respiratory Infections in the Structure of SARS in Children. Detskie infektsii. 2015;(2):5-11. (In Russ.)
Kharlamova FS, Bevza SL, Sergeeva AM, Necterenko VG, Uchajkin VF. Prevention efficacy of Kagocel for treatment of acute respiratory viral infections in children. Detskie infektsii. 2009(4);34-40. (In Russ.)
Kharlamova FS, Utchaykin VF, Kladova OV, Sergeeva EM, Nesterenko VG. Clinical and preventive efficacy of interferon inductor in viral respiratory tract infections in children younger preschool age. Pediatricheskaya farmakologiya. 2012; 1(9);81-89. (In Russ.)
Fazylov VKH, Sitnikov IG, Malyshev NA, Silina EV, Shevchenko SB, Eganyan GA, Korsantiya BM, Groppa LG. The effect of antiviral therapy on the incidence of bacterial complications and the prescription of antibacterial drugs for systemic use in patients with influenza and ARVI (the results of a cohort international observational study). Antibiotics and chemotherapy. 2016;61(11-12):39-47. (In Russ.)
Popov AF, Simakova AI, Dmitrenko MYu, Shchelkanov MYu. Increase in the anti-influenza efficacy of Oseltamivir (Tamiflu) and Umifenovir (Arbidol) by combined use with Kagocel. Antibiotics and chemotherapy. 2017; 62(1-2):25-29. (In Russ.)
Fazylov VKh, Sitnikov IG, Silina EV and etc. Treatment of acute respiratory viral infections and influenza in routine clinical practice (results of a multicentre international observational study FLU-EE). Therapeutic archive. 2016;11:61-68. (In Russ.)